ADVERTISEMENT
About
Engage
Bookstore
My Account
Contact Us
Membership
Join
Practitioners
Scientists
Student Pharmacists
New Practitioner Network
Get Involved
Health System Pharmacy
Volunteer
APhA Elections
2023 Board of Trustee and Honorary President Candidates
2023 APhA-APRS Officer Candidates
2023 APhA-APPM Officer Candidates
2023 APhA-APPM SIG Coordinator-elect Candidates
Special Interest Groups
Sections
House of Delegates
Awards
Education
NEW Learning Library
My Training
Search Education
eLearning
Self-Paced Courses
Advanced Training
Quick Quizzes
Hot Topic Courses
Live Education
Certificate Training Programs
Immunization
Diabetes Care
Medication Therapy Management
Pharmacy-Based Test And Treat
Comprehensive Pain Management
More Programs
Board Prep & Recertification
Ambulatory Care
Sterile Compounding
Licensed Partners
Show You Know
Education FAQs
Advocacy
Issues
APhA PAC
Advocacy Action Center
Well-Being and Resiliency
APhA DEIB Committee
Legal Defense Fund
Career
Career Center
Job Board
Career Pathways
Residencies
Post Graduate Opportunities
Technician Careers
APhA ADVANCE
Pharmacy Profiles
Conferences
Annual Meeting
Joint Federal Pharmacy Seminar
Day of New Practitioner LIFE
Midyear Regional Meeting
APhA Institute on Substance Use Disorders
Summer Leadership Institute
Practice
COVID-19
Patient Care Services
Chronic Disease Management
Medication Management
Opioid Use & Misuse
Tobacco Cessation
Transitions of Care Resources
Compounding
Medication Safety & Access
Nuclear
Specialty
Immunization Center
Practice Resources
Billing & Payment Center
Health Information Technology
Technicians
Telehealth
Quality
Research & Evidence
Scope of Practice
Social Determinants of Health
Learn the Lingo
Team-based Partnerships
Pulse On Practice & Policy
Preceptors
PharmacotherapyFirst
Publications
JAPhA
Pharmacy Today
JPharmSci
Student Pharmacist Magazine
Transitions
Podcasts
PharmacyLibrary
Books
Login
JOIN / RENEW
State and Federal Developments
Resources that reflect developments regarding federal and state responses to the opioid epidemic.
Overview of Pharmacists’ Prescriptive Authority of Controlled Substances
Pharmacist Controlled Substance Authority by State
X-Waiver Requirement Removal FAQ (SAMHSA)
Opioid Analgesic REMS
REMS Compliant Continuing Education
Opioid Analgesic REMS Patient Counseling Guide
Medication Guides
National Prescription Drug Take Back Day event
(DEA)
National Prescription Drug Take Back Day
(DEA)
Reducing Opioid Misuse Letter to Providers
(CMS)
2019 Medicare Part D Opioid Policies: Information for Pharmacies (Tip Sheet) (a webinar is also available) (CMS)
Opioid Prescribing by Specialty and Volume in the U.S. (CDC)
Surgeon General's Spotlight on Opioids: Facing Addiction in America
Help, Resources and Information, National Opioid Crisis
(HHS)
5-Point Strategy to Combat the Opioid Crisis
HEAL Initiative Research Plan
(NIH)
Surgeon General's Advisory on Naloxone and Opioid Overdose
(April 2018)
DEA 360 Strategy
Opioids
(Agency for Health Research and Quality)
White House: The Opioid Crisis
Naloxone Access in Community Pharmacies
(National Alliance of State Pharmacy Associations)
The Surgeon General's Report on Alcohol, Drugs, and Health - Facing Addiction in America
(November 2016)
National Pain Strategy (HHS)
Preventing the Consequences of Opioid Overdose: Understanding Naloxone Access Laws (SAMHSA)
National and state treatment need and capacity for opioid antagonist medication-assisted treatment
Fact Sheet – FDA Opioids Action Plan
Prescription Drug Time and Dosage Limit Laws
(CDC)
The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse (CMS)
State Laws on Prescription Drug Abuse and Misuse
(CDC)
x
ADVERTISEMENT